Skip to main content

Table 6 Interaction between MYBL2 expression and radiotherapy on HGG glioma survival

From: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

MYBL2 expression

Radiotherapy

Patients

Deaths

MST(Months)

Adjusted HR (95% CI)

P*

High

Yes

136

127

4.9

1

 

High

No

404

292

9.6

5.29 (1.475-18.969)

0.011*

Low

Yes

10

8

1.5

0.995 (0.335-2.958)

0.993

Low

No

17

12

7.7

1.769 (0.267-11.697)

0.554

  1. *p-vale<0.05; Abbreviations: MST median survival time
  2. Adjusted for age, gender, race, and history neoadjuvant treatment